| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90b6a94203592576ea1f73ac2c925ec0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5c07cda0a59b0fb31005b585dbccd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3a36e8da91739ef0c946b2d1580ab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ddae77e0b8c839e50fd19d79ae76fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5f7f2454939320442b03cbd3076676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17df074496cf0bda5f16bdda173f485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41916133e0d07aa4d365cc99203c1bed |
| publicationDate |
2005-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2224408-T3 |
| titleOfInvention |
BENZOPIRIDOCICLOHEPTANO USEFUL COMPOUNDS FOR THE INHIBITION OF FARNESIL-PROTEIN-TRANSFERASE. |
| abstract |
The present invention relates to new compounds represented by the formula (1.0). The present invention also relates to a method of inhibiting the function of farnesyl protein transferase and consequently of abnormal cell growth. This procedure consists in administering a compound of the formula (1.0) to a biological system. This procedure inhibits in particular the abnormal growth of cells in mammals such as man. |
| priorityDate |
1997-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |